Strafford will be offering a webinar entitled "Supplemental Examination Requests: Benefits and Limitations, Strategic Use -- Assessing Enforceability of Patent Portfolios, Evaluating the High Burden" on May 9, 2018 from 1:00 to 2:30 pm (EDT). Thomas L. Irving, Amanda K. Murphy, and Jennifer S. Swan of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel on supplemental examination requests generally and specific to chemical patents, examine the supplemental examination successes and its limitations, and provide insight on the strategic use of supplemental examinations. The webinar will review the following issues:
• How should counsel balance the benefits and limitations of supplemental examination before filing a request?
• What are the burdens for patent owners considering a request for supplemental examination?
• How can pharma patent owners leverage the patent system along with the drug approval process?
• What is the impact on supplemental examination?
The registration fee for the webcast is $297. Those interested in registering for the webinar, can do so here.